| Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation B Orlikova-Boyer, A Lorant, SR Gajulapalli, C Cerella, M Schnekenburger, ... Biomarker Research 12 (1), 47, 2024 | | 2024 |
| ATP1A1/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosides C Cerella, SR Gajulapalli, A Lorant, D Gerard, F Muller, Y Lee, KR Kim, ... Leukemia 38 (1), 67-81, 2024 | | 2024 |
| Enhancing personalized immune checkpoint therapy by immune archetyping and pharmacological targeting C Cerella, M Dicato, M Diederich Pharmacological Research, 106914, 2023 | 2 | 2023 |
| Marine polyether phycotoxin palytoxin induces apoptotic cell death via Mcl-1 and Bcl-2 downregulation J Kim, S Ji, JY Lee, J Lorquin, B Orlikova-Boyer, C Cerella, A Mazumder, ... Marine drugs 21 (4), 233, 2023 | 1 | 2023 |
| Immune-modulating and anti-inflammatory marine compounds against cancer C Florean, M Dicato, M Diederich Seminars in Cancer Biology 80, 58-72, 2022 | 41 | 2022 |
| Phytochemical Screening and Antioxidant and Cytotoxic Effects of Acacia macrostachya HT Ganamé, Y Karanga, I Tapsoba, M Dicato, MF Diederich, C Cerella, ... Plants 10 (7), 1353, 2021 | 8 | 2021 |
| Assessment of mitochondrial cell metabolism by respiratory chain electron flow assays F Radogna, D Gerard, M Dicato, M Diederich Mitochondrial Medicine: Volume 2: Assessing Mitochondria, 129-141, 2021 | 3 | 2021 |
| Susceptibility of multiple myeloma to B-cell lymphoma 2 family inhibitors M Lernoux, M Schnekenburger, M Dicato, M Diederich Biochemical Pharmacology 188, 114526, 2021 | 3 | 2021 |
| Anti-leukemic properties of aplysinopsin derivative ee-84 alone and combined to bh3 mimetic a-1210477 S Song, S Kim, ER El-Sawy, C Cerella, B Orlikova-Boyer, G Kirsch, ... Marine drugs 19 (6), 285, 2021 | 10 | 2021 |
| Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells M Lernoux, M Schnekenburger, H Losson, K Vermeulen, H Hahn, ... Clinical Epigenetics 12, 1-26, 2020 | 20 | 2020 |
| BH3 mimetics in AML therapy: death and beyond? C Cerella, M Dicato, M Diederich Trends in Pharmacological Sciences 41 (11), 793-814, 2020 | 22 | 2020 |
| The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia H Losson, SR Gajulapalli, M Lernoux, JY Lee, A Mazumder, D Gérard, ... Pharmacological Research 160, 105058, 2020 | 10 | 2020 |
| Inflammation regulates long non-coding RNA-PTTG1-1: 1 in myeloid leukemia S Chateauvieux, A Gaigneaux, D Gérard, M Orsini, F Morceau, ... haematologica 105 (6), e280, 2020 | 2 | 2020 |
| Total synthesis of (±)-cassumunins a–c and curcumin analogues MA Hussain, FA Khan Synthesis 52 (10), 1561-1575, 2020 | 3 | 2020 |
| N-methyl-D-aspartate receptor hypofunction in Meg-01 cells reveals a role for intracellular calcium homeostasis in balancing megakaryocytic-erythroid differentiation JI Hearn, TN Green, M Chopra, YNS Nursalim, L Ladvanszky, N Knowlton, ... Thrombosis and Haemostasis 120 (04), 671-686, 2020 | 12 | 2020 |
| Epigenetic mechanisms underlying the therapeutic effects of HDAC inhibitors in chronic myeloid leukemia M Lernoux, M Schnekenburger, M Dicato, M Diederich Biochemical pharmacology 173, 113698, 2020 | 19 | 2020 |
| Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia S Song, JY Lee, L Ermolenko, A Mazumder, S Ji, H Ryu, HJ Kim, DW Kim, ... Cell death & disease 11 (2), 109, 2020 | 30 | 2020 |
| HDAC6—an emerging target against chronic myeloid leukemia? H Losson, M Schnekenburger, M Dicato, M Diederich Cancers 12 (2), 318, 2020 | 27 | 2020 |
| Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells C Grandjenette, M Schnekenburger, A Gaigneaux, D Gerard, C Christov, ... Cancer Letters 469, 468-480, 2020 | 11 | 2020 |
| Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells M Orsini, S Chateauvieux, J Rhim, A Gaigneaux, D Cheillan, C Christov, ... Cell Death & Differentiation 26 (9), 1796-1812, 2019 | 77 | 2019 |
